IRIDOX · The Synergistic Merging of Iridium-Catalysed Hydrogen Borrowing and Asymmetric Catalysis in the Pursuit of Enantioenriched Small Molecules
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2018-08-14 → 2020-08-13
- EU contribution
- €183,455
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
The Synergistic Merging of Iridium-Catalysed Hydrogen Borrowing and Asymmetric Catalysis in the Pursuit of Enantioenriched Small Molecules
"The action ""IRIDOX"" looked at the development of new synthetic organic methodologies using iridium catalysis, in conjunction with other techniques, to develop the synthesis of small biologically relevant heterocycles. Heterocycles, small organic molecules that feature both carbon and other atoms (normally nitrogen or oxygen) in a ring, are incredibly important structural motifs for the development of pharmaceuticals and agrochemicals. These types of structures can be found in almost all commercially available drugs and herbicides. Therefore, it is of considerable importance for chemists to develop methods to construct and prepare such target molecules, allowing the more rapid synthesis of such targets. This project aims to assist this goal by developing new methods to prepare piperidines (an important class of heterocycle) from cheap and commercially available precursors using a metal-catalyst (nominally iridium, but later it was found that related metals such as rhodium and ruthenium were also competent for such transformations, and in some cases, found to be superior. The development of chemical methodologies to prepare such synthetic targets is of great importance for society as it will enable the faster and more efficient synthesis of pharmaceuticals and allow the development of new medicines to treat diseases and medical issues. The project completed its goal by developing 5 new methodologies (work packages) that enable the synthesis of a number of different desirable heterocycles, each of these methods use either iridium/rhodium/ruthenium catalysts or catalyst free. Each of the 5 methodologies developed represents an important step towards more efficient drug synthesis. Additionally, each work package relies a one carbon equivalent and hydrogen and uses either methanol, formaldehyde, or formic acid as the key sources. Each of these three chemicals are cheap and abundant feedstock chemicals, thus increasing the environmentally friendly nature of each of these transformations."
Data: CORDIS, © European Union
Project objective
Hydrogen-borrowing catalysis is a fantastically powerful method of constructing new bonds and synthesising key small organic molecules. However, despite recent advances, many hydrogen-borrowing methodologies do not embrace asymmetric catalysis, limiting its use in targeted synthesis of chiral molecules.The goal of this proposal is to address these issues and develop new methodologies that involve enantioinduction. In particular,focusing on using hydrogen-borrowing catalysis in combination with forms of asymmetric catalysis (such as organocatalysis) and using hydrogen-borrowing catalysis to transiently activate substrates in order to facilitate reactions that appear unlikely to occur on paper. Following the development of these methodologies, they will be applied to the synthesis of biologically active molecules and natural products.The high quality and novel research contained within these goals will be met due to the knowledge and experience of the experience researcher and the host, Professor Timothy J. Donohoe, along with the excellent facilities and opportunities afford by the University of Oxford.Following the completion of the research, the results will be highly interesting and useful to the greater chemistry community in both academia and industry.
Original text from CORDIS.
Participants
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union
